86891-18-1

Basic information

• Product Name: (5R,8S,10R)-6-cyano-8-methoxycarbonylergoline
• Synonyms: (5R,8S,10R)-6-cyano-8-methoxycarbonylergoline
• CAS NO: 86891-18-1
• Molecular Weight: 295.341
• Mol File: 86891-18-1.mol
• Article Data: 0

Chemical Properties

• Boiling Point: 555.9±50.0 °C(Predicted)
• Density: 1.35±0.1 g/cm3(Predicted)
• CAS DataBase Reference: (5R,8S,10R)-6-cyano-8-methoxycarbonylergoline(CAS DataBase Reference)
• NIST Chemistry Reference: (5R,8S,10R)-6-cyano-8-methoxycarbonylergoline(86891-18-1)
• EPA Substance Registry System: (5R,8S,10R)-6-cyano-8-methoxycarbonylergoline(86891-18-1)

Safety Data

• Hazardous Substances Data: 86891-18-1(Hazardous Substances Data)

Usage

Description

(5R,8S,10R)-6-cyano-8-methoxycarbonylergoline, also known as 6-CE, is a synthetic chemical compound derived from the ergoline family of alkaloids. It is structurally related to lysergic acid diethylamide (LSD) and is known for its psychoactive and hallucinogenic effects. 6-CE is not naturally occurring and is typically synthesized in a laboratory setting. Research into its pharmacology and potential therapeutic applications is ongoing, with a focus on its potential use in treating various mental health conditions.

Uses

Used in Pharmaceutical Industry:
6-CE is used as a research compound for its psychoactive and hallucinogenic properties, which are similar to those of LSD. It is being investigated for potential therapeutic applications in the treatment of various mental health conditions, such as depression, anxiety, and post-traumatic stress disorder (PTSD). (5R,8S,10R)-6-cyano-8-methoxycarbonylergoline's ability to modulate serotonin receptors in the brain makes it a promising candidate for further research and development in the field of psychopharmacology.
Used in Research and Development:
6-CE is used as a research tool in the study of the ergoline family of alkaloids and their effects on the central nervous system. Its structural similarity to LSD allows scientists to explore the mechanisms of action and potential therapeutic uses of hallucinogenic compounds. Additionally, 6-CE can be used to develop new synthetic methods and improve the understanding of the structure-activity relationship within the ergoline family.
Used in Drug Delivery Systems:
While not explicitly mentioned in the provided materials, it is plausible that 6-CE could be used in drug delivery systems similar to those developed for gallotannin. Novel drug delivery systems could be designed to enhance the bioavailability, delivery, and therapeutic outcomes of 6-CE, particularly if its potential therapeutic applications in mental health conditions are further validated. These systems could include organic and metallic nanoparticles or other advanced drug delivery technologies to improve the compound's efficacy and safety profile.

Downstream Products

• 86891-15-8 (6aR,9S,10aR)-7-Allyl-4,6,6a,7,8,9,10,10a-octahydro-indolo[4,3-fg]quinoline-9-carboxylic acid